CAS 120511-73-1
:Anastrozole
Description:
Anastrozole is a non-steroidal aromatase inhibitor primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Its mechanism of action involves the inhibition of the aromatase enzyme, which is responsible for converting androgens into estrogens, thereby reducing estrogen levels in the body. This reduction is crucial as many breast cancers are fueled by estrogen. Anastrozole is typically administered orally and is known for its favorable pharmacokinetic profile, including good absorption and a relatively long half-life, allowing for once-daily dosing. Common side effects may include hot flashes, joint pain, and fatigue, among others. The substance is classified as a prescription medication and is often part of adjuvant therapy following surgery or radiation. Anastrozole is recognized for its effectiveness in improving disease-free survival rates in breast cancer patients, making it a significant option in oncological pharmacotherapy. Its chemical structure features a triazole ring, contributing to its specificity and efficacy as an aromatase inhibitor.
Formula:C17H19N5
InChI:InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3
InChI key:InChIKey=YBBLVLTVTVSKRW-UHFFFAOYSA-N
SMILES:C(C#N)(C)(C)C1=CC(C(C#N)(C)C)=CC(CN2C=NC=N2)=C1
Synonyms:- 1,3-Benzenediacetonitrile, α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-Benzenediacetonitrile,Alpha,Alpha,Alpha',Alpha'-Tetramethyl-5-(1H-1,2,4-Triazol-1-Ylmethyl)-
- 1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
- 1-[3,5-Di-(1-Methyl-1-Cyano)-Ethyl]-Benzyl-1,2,4-Triazole
- 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
- 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)
- 2-[3-(1-Cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile
- 2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile
- 2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
- Anastrazole
- Anastrol
- Anastrozol
- Anatrozole
- Arimidex
- Ici-D-1033
- Tetramethyl-5-(1H-1,2,4-Triazol-1Ylmethyl) 1,3-Benzenediacetionitrile
- Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile
- ZD-1033, ICI-D-1033, Arimidex
- Zd
- Zd-1033
- α<sup>1</sup>,α<sup>1</sup>,α<sup>3</sup>,α<sup>3</sup>-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
- Anastrozole
- 1,3-Benzenediacetonitrile, α1,α1,α3,α3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- 1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)-
- zd
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Anastrozole
CAS:Formula:C17H19N5Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:293.37Anastrozole
CAS:AnastrozoleFormula:C17H19N5Purity:99.7%Color and Shape:WhiteMolecular weight:293.16405Anastrozole
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C17H19N5Color and Shape:Off-White PowderMolecular weight:293.16405Anastrozole
CAS:Anastrozole (ZD1033)(ZD1033), a potent and highly selective aromatase (CYP19) inhibitor (IC50 = 15 nM), has no obvious effect on adrenocorticoid hormoneFormula:C17H19N5Purity:99.73% - 99.84%Color and Shape:Crystalline SolidMolecular weight:293.37Anastrozole
CAS:Formula:C17H19N5Purity:≥ 98.0%Color and Shape:White to beige powder or crystalsMolecular weight:293.37Anastrozole
CAS:Controlled Product<p>Applications An aromatase inhibitor. Used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Formula:C17H19N5Color and Shape:NeatMolecular weight:293.37Anastrozole - Bio-X ™
CAS:Controlled Product<p>Anastrozole is a non-steroidal drug that belongs to the class of aromatase inhibitors. It inhibits the production of estrogen by blocking the conversion of androgens to estrogens in peripheral tissues. The drug has been shown to be effective in treating breast cancer in postmenopausal women. In vitro assays have shown that Anastrozole can inhibit tumor growth as well as induce apoptosis in human serum cells, which suggests that it may be effective against a variety of cancers.</p>Formula:C17H19N5Purity:Min. 95%Color and Shape:PowderMolecular weight:293.37 g/molAnastrozole
CAS:Controlled Product<p>Inhibits aromatase (CYP19) enzyme; antineoplastic</p>Formula:C17H19N5Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:293.37 g/mol













